Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now

NYSE - Nasdaq Real Time Price USD

Medifast, Inc. (MED)

Compare

14.73

+0.40

+(2.79%)

At close: February 21 at 4:00:02 PM EST

14.95

+0.22

+(1.49%)

After hours: February 21 at 6:50:07 PM EST

Medifast Full Year 2024 Earnings: EPS Beats Expectations

Medifast ( NYSE:MED ) Full Year 2024 Results Key Financial Results Revenue: US$602.5m (down 44% from FY 2023). Net...

Simply Wall St. 3 days ago

MED
+2.79%
MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition

Medifast's Q2 results show challenges related to weak customer acquisition. However, it is prioritizing efforts to enhance coach productivity in the near term.

Zacks 4 days ago

MED
+2.79%
USFD
Medifast Inc (MED) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

Despite a significant revenue decline, Medifast Inc (MED) focuses on cost savings and new product launches to drive future growth.

GuruFocus.com 4 days ago

MED
+2.79%
Medifast (MED) Q4 Earnings and Revenues Beat Estimates

Medifast (MED) delivered earnings and revenue surprises of 137.04% and 7.70%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 5 days ago

MED
+2.79%
SJM
Medifast: Q4 Earnings Snapshot

The weight-loss company posted revenue of $119 million in the period. For the year, the company reported profit of $2.1 million, or 19 cents per share. Revenue was reported as $602.5 million.

Associated Press Finance 5 days ago

MED
+2.79%
Medifast (NYSE:MED) Surprises With Q4 Sales But Quarterly Revenue Guidance Significantly Misses Expectations

Wellness company Medifast (NYSE:MED) beat Wall Street’s revenue expectations in Q4 CY2024, but sales fell by 37.7% year on year to $119 million. On the other hand, next quarter’s revenue guidance of $110 million was less impressive, coming in 15.9% below analysts’ estimates. Its GAAP profit of $0.07 per share was significantly above analysts’ consensus estimates.

StockStory 5 days ago

MED
+2.79%
Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

BALTIMORE, February 18, 2025--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2024.

Business Wire 5 days ago

MED
+2.79%
Medifast (MED) Q4 Earnings Report Preview: What To Look For

Wellness company Medifast (NYSE:MED) will be announcing earnings results tomorrow after the bell. Here’s what you need to know.

StockStory 6 days ago

MED
+2.79%
What Is Medifast, Inc.'s (NYSE:MED) Share Price Doing?

While Medifast, Inc. ( NYSE:MED ) might not have the largest market cap around , it received a lot of attention from a...

Simply Wall St. 7 days ago

MED
+2.79%
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024

BALTIMORE, February 04, 2025--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2024 on Tuesday, February 18, 2025, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chi

Business Wire 19 days ago

MED
+2.79%
MED Focused on GLP-1 Solutions Amid Customer Acquisition Challenges

With a strategic focus on innovation and a robust operational framework, Medifast is well-placed for growth in the weight loss and GLP-1 medication space.

Zacks last month

MED
+2.79%
Medifast Launches OPTAVIA ASCEND for Weight Loss Management

MED's new OPTAVIA ASCEND product line combines high-protein meals, fiber-rich nutrients and personalized coaching.

Zacks last month

MED
+2.79%
USFD
Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off

BALTIMORE, January 07, 2025--Medifast (NYSE:MED), the health and wellness company known for its habit based and coach-guided lifestyle solution OPTAVIA, today announced OPTAVIA ASCEND — a new product line of high-protein, fiber-rich mini meals as well as a daily nutrient pack. These products are featured in two new science-backed nutrition plans designed for people on GLP-1 medications and those looking for help to keep weight off. The mini meals provide essential nutrients to promote muscle hea

Business Wire last month

MED
+2.79%
3 Consumer Stocks to Drop Right Now

Consumer staples are considered safe havens in turbulent markets due to their inelastic demand profiles. The flip side is that they frequently fall behind growth industries when times are good. This trade-off has yet to emerge as the sector has posted a 10.3% return over the past six months, almost identical to the S&P 500.

StockStory 2 months ago

MGPI

STKL

MED
+2.79%
Is Medifast, Inc.'s (NYSE:MED) Stock Price Struggling As A Result Of Its Mixed Financials?

With its stock down 15% over the past week, it is easy to disregard Medifast (NYSE:MED). It is possible that the...

Simply Wall St. 2 months ago

MED
+2.79%
How To Use Powerful Breakaway Gaps To Buy Potentially Big Stock Market Leaders

Breakaway gaps — when a stock gaps up so strongly in price that it rises past a proper buy point — are powerful advances that can lead to more upside.

Investor's Business Daily 2 months ago

MED
+2.79%
Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications

BALTIMORE, December 05, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today shared findings from a recent independent survey. Commissioned by Medifast and conducted by the third-party market research firm Talker Research, the goal of the survey was to better understand American perceptions of weight loss medications and their role in health journeys, while also identifying areas where further support is necessa

Business Wire 2 months ago

MED
+2.79%
Medifast (MED) Down 5.8% Since Last Earnings Report: Can It Rebound?

Medifast (MED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Zacks 2 months ago

MED
+2.79%
SYY
Three Reasons to Avoid MED and One Stock to Buy Instead

What a brutal six months it’s been for Medifast. The stock has dropped 20.6% and now trades at $19.84, rattling many shareholders. This may have investors wondering how to approach the situation.

StockStory 2 months ago

MED
+2.79%
Spotting Winners: Nu Skin (NYSE:NUS) And Personal Care Stocks In Q3

Let’s dig into the relative performance of Nu Skin (NYSE:NUS) and its peers as we unravel the now-completed Q3 personal care earnings season.

StockStory 2 months ago

NUS
-1.68%
HNST

MED
+2.79%

Performance Overview

Return	MED	S&P 500
YTD	-16.40%	+2.24%
1-Year	-63.52%	+20.70%
3-Year	-90.78%	+38.27%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Medifast, Inc. (MED)

Medifast Full Year 2024 Earnings: EPS Beats Expectations

MED Q4 Earnings Beat, Revenues Dip Y/Y on Lower Customer Acquisition

Medifast Inc (MED) Q4 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...

Medifast (MED) Q4 Earnings and Revenues Beat Estimates

Medifast: Q4 Earnings Snapshot

Medifast (NYSE:MED) Surprises With Q4 Sales But Quarterly Revenue Guidance Significantly Misses Expectations

Medifast Announces Fourth Quarter and Full Year 2024 Financial Results

Medifast (MED) Q4 Earnings Report Preview: What To Look For

What Is Medifast, Inc.'s (NYSE:MED) Share Price Doing?

Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2024

MED Focused on GLP-1 Solutions Amid Customer Acquisition Challenges

Medifast Launches OPTAVIA ASCEND for Weight Loss Management

Medifast Introduces New High-Protein Product Line OPTAVIA ASCEND™ For GLP-1 Users & Those Looking for Help to Keep Weight Off

3 Consumer Stocks to Drop Right Now

Is Medifast, Inc.'s (NYSE:MED) Stock Price Struggling As A Result Of Its Mixed Financials?

How To Use Powerful Breakaway Gaps To Buy Potentially Big Stock Market Leaders

Medifast Survey Finds Majority of U.S. Adults Trying to Lose Weight Agree Lifestyle Changes Are Essential – Even with Weight Loss Medications

Medifast (MED) Down 5.8% Since Last Earnings Report: Can It Rebound?

Three Reasons to Avoid MED and One Stock to Buy Instead

Spotting Winners: Nu Skin (NYSE:NUS) And Personal Care Stocks In Q3

Performance Overview